Bfsg LLC Acquires New Position in 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT)

Bfsg LLC acquired a new stake in shares of 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 1,500 shares of the company’s stock, valued at approximately $30,000. A number of other institutional investors and hedge funds […]

Related Keywords

United States ,David Kirn ,Scott Bizily ,Panagora Asset Management Inc ,Mt Bank Corp ,Nasdaq ,T Bank Corp ,Sg Americas Securities ,D Molecular Therapeutics Inc ,Jefferies Financial Group ,Goldman Sachs Group ,York Mellon Corp ,Barclays ,Affinity Wealth Management ,Molecular Therapeutics ,Free Report ,Wealth Management ,New York Mellon Corp ,Asset Management ,Financial Group ,Molecular Therapeutics Trading Down ,Get Free Report ,Molecular Therapeutics Daily ,4d Molecular Therapeutics ,Nasdaq Fdmt ,Fdmt ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,